AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

2 weeks ago

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

Prezent Sets New Milestones with Record Revenue in 2024, Unveils AI-Driven Vision for Enterprise Communication, and Secures Backing from New Investors True Global Ventures and Zoom Ventures to Accelerate Hyper-Growth in 2025

2 weeks ago

LOS ALTOS, Calif., Dec. 9, 2024 /PRNewswire/ -- Prezent, the Enterprise Business Storytelling Platform, announced today multiple key milestones achieved in…

Bioz Stars Awards 2024: Recognizing the World’s Top Suppliers in Scientific Innovation

2 weeks ago

PALO ALTO, CA / ACCESSWIRE / December 9, 2024 / Bioz, Inc, a leader in AI-powered solutions for scientific research,…

CeraVx B.V. Emerges from Stealth Acquires Micro Needle Technology from MLT Appoints Management and Supervisory Board

2 weeks ago

CeraVx BV successful bid to acquire key micro needle technology from MLTManagement team:Dr. Jan Groen as CEO,Dinja Oosterhof , PhD…

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment

2 weeks ago

VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience…

Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed

2 weeks ago

Hemogenyx Pharmaceuticals Successfully Completes the Site Initiation Visit of the First Clinical Site for Phase I Clinical Trial of HG-CT-1…

Scryb Launches New AI Governance Technology Business Unit, ‘Raidian’

2 weeks ago

Toronto, Ontario--(Newsfile Corp. - December 8, 2024) - Scryb Inc.  (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is pleased…

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

2 weeks ago

Media ReleaseCOPENHAGEN, Denmark; December 7, 2024 Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and…